-
1دورية أكاديمية
المؤلفون: Guarneri V., Bassan F., Zagonel V., Milella M., Zaninelli M., Cattelan A. M., Vianello A., Gori S., Aprile G., Azzarello G., Chiari R., Favaretto A., Oliani C., Scola A., Pastorelli D., Mandara M., Zustovich F., Bernardi D., Chiarion-Sileni V., Morandi P., Toso S., Di Liso E., Ziampiri S., Caccese M., Zampiva I., Puccetti O., Celestino M., Dieci M. V., Conte P.
المساهمون: Guarneri, V., Bassan, F., Zagonel, V., Milella, M., Zaninelli, M., Cattelan, A. M., Vianello, A., Gori, S., Aprile, G., Azzarello, G., Chiari, R., Favaretto, A., Oliani, C., Scola, A., Pastorelli, D., Mandara, M., Zustovich, F., Bernardi, D., Chiarion-Sileni, V., Morandi, P., Toso, S., Di Liso, E., Ziampiri, S., Caccese, M., Zampiva, I., Puccetti, O., Celestino, M., Dieci, M. V., Conte, P.
مصطلحات موضوعية: Chemotherapy, COVID-19, Mortality, Patients with cancer, SARS-CoV-2 infection, Adult, Aged, 80 and over, Community Network, Disease Progression, Female, Hospital Mortality, Hospitalization, Human, Intensive Care Unit, Italy, Male, Middle Aged, Neoplasm, Pandemic, Prognosi, Registrie, SARS-CoV-2, Severity of Illness Index
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33647547; info:eu-repo/semantics/altIdentifier/wos/WOS:000631689400015; volume:147; firstpage:120; lastpage:127; numberofpages:8; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11577/3394806Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101651036
-
2دورية أكاديمية
المؤلفون: Zanelli, S, Fiorio, E, Zampiva, I, Zacchi, F, Borghesani, G, Giontella, E, Parolin, V, Biondani, P, Zuliani, S, Dieci, M V, Mioranza, E, Zorzi, M, Conti, M, Gibellini, D, Verlato, G, Milella, M
المساهمون: Zanelli, S, Fiorio, E, Zampiva, I, Zacchi, F, Borghesani, G, Giontella, E, Parolin, V, Biondani, P, Zuliani, S, Dieci, M V, Mioranza, E, Zorzi, M, Conti, M, Gibellini, D, Verlato, G, Milella, M
مصطلحات موضوعية: Breast cancer, COVID-19, chemotherapy, disease severity, endocrine therapy
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35276335; info:eu-repo/semantics/altIdentifier/wos/WOS:000806396900015; volume:33; issue:6; firstpage:661; lastpage:663; numberofpages:3; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11562/1059538Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131042663
-
3دورية أكاديمية
المؤلفون: Bazzichetto C., Milella M., Zampiva I., Simionato F., Amoreo C. A., Buglioni S., Pacelli C., Le Pera L., Colombo T., Bria E., Zeuli M., Del Bufalo D., Sperduti I., Conciatori F.
المساهمون: Bazzichetto, C., Milella, M., Zampiva, I., Simionato, F., Amoreo, C. A., Buglioni, S., Pacelli, C., Le Pera, L., Colombo, T., Bria, E., Zeuli, M., Del Bufalo, D., Sperduti, I., Conciatori, F.
مصطلحات موضوعية: IL-8, advanced CRC, anti-angiogenic drug, chemotherapy, prognosi, tumor–stroma interactions
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36289899; info:eu-repo/semantics/altIdentifier/wos/WOS:000872610900001; volume:10; issue:10; firstpage:2631; journal:BIOMEDICINES; https://hdl.handle.net/11573/1670563Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85140636787
